Drugs / Acidulated Phosphate Fluoride
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT07371117 | Nov 2025 → Feb 2026 | dental caries | University of Jazan | Completed | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT06837779 | Jul 2024 → Aug 2025 overdue | dentin sensitivity | Al-Azhar University | Enrolling by invitation | No outcome recorded |
| — | NCT05588518 | Apr 2019 → Feb 2020 | dentin sensitivity | King Khalid University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Acidulated Phosphate Fluoride | “Acidulated Phosphate Fluoride (APF) gel are widely employed chemotherapeutic agents” NCT07371117 ↗ |
| Known as | APF | “Acidulated Phosphate Fluoride (APF) gel are widely employed chemotherapeutic agents” NCT07371117 ↗ |
| Route | Other | “Application of fluoride gel and activated with Iontophoresis electrical pole” NCT06837779 ↗ |